BIRC2 and colorectal carcinoma: Additionally, FOLFOX was shown to promote tolinapant-induced apoptosis in human CRC and murine organ models, providing evidence for the clinical exploration of tolinapant in combination with FOLFOX for the treatment of cIAP1-expressing CRC with poor prognosis and high microsatellite stability (Crawford et al.2021).